Amneal Pharmaceuticals, Inc. (AMRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

SA Transcripts158.9K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Amneal Pharmaceuticals, Inc. (AMRX) Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:00 AM EDT Company Participants Chirag Patel - Co-Founder, Co-CEO, President & Director Conference Call Participants Glen Santangelo - Barclays Bank PLC, Research Division Presentation Glen SantangeloBarclays Bank PLC, Research Division All right. Good morning, everyone. Thank you for joining us for our next presentation. We're excited to be hosting Amneal Pharmaceuticals. Chirag Patel to my left is the Co-Chief Executive Officer and President of the company. In the front row, we got Joe Kates, who does all things finance. And to his left, my right, would be Tony DiMeo, who heads the Investor Relations function that I think many of you know. So we're excited to have you here. Thank you for joining us. Why don't we just jump right into it? I probably should have mentioned, I'm Glen Santangelo. I'm the analyst at Barclays that covers the stock. We launched in December with an outperform rating. Amneal is new coverage for us here at Barclays. So we're pretty excited about it. So thank you for joining us. Question-and-Answer Session Glen SantangeloBarclays Bank PLC, Research Division Maybe a good place to start is we're week, 1.5 weeks off your 4Q results. I mean you wrapped up a very successful 2025. Maybe that's a good place to start and just give people just a quick recap of 2025 and those 4Q results and set the table for 2026 with your guidance. And I don't know if there was anything that surprised you -- I mean there was a lot that maybe surprised you the upside, anything to the downside that might have surprised you coming out of fiscal '25. Chirag PatelCo-Founder, Co-CEO, President & Director Great. Thank you, Glen. Thank you for hosting Amneal here and